152 related articles for article (PubMed ID: 38626389)
21. Interference of MIBG uptake by medication: a case report.
Apeldoorn L; Voerman HJ; Hoefnagel CA
Neth J Med; 1995 May; 46(5):239-43. PubMed ID: 7783826
[TBL] [Abstract][Full Text] [Related]
22. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
[TBL] [Abstract][Full Text] [Related]
23. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
[TBL] [Abstract][Full Text] [Related]
24. Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure.
Jacobson AF; White S; Travin MI; Tseng C
Nucl Med Commun; 2017 Feb; 38(2):141-148. PubMed ID: 27861299
[TBL] [Abstract][Full Text] [Related]
25. Sympathetic reinnervation demonstrated on serial iodine-123-metaiodobenzylguanidine SPECT images after cardiac transplantation.
Toba M; Ishida Y; Fukuchi K; Shimotsu Y; Takamiya M; Komamura K; Nakatani T; Ohuchi H; Ono Y; Kamiya T
J Nucl Med; 1998 Nov; 39(11):1862-4. PubMed ID: 9829571
[TBL] [Abstract][Full Text] [Related]
26. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy.
Fukuoka S; Hayashida K; Hirose Y; Shimotsu Y; Ishida Y; Kakuchi H; Eto T
Eur J Nucl Med; 1997 May; 24(5):523-9. PubMed ID: 9142733
[TBL] [Abstract][Full Text] [Related]
27. Potential for Increasing Uptake of Radiolabeled
Pollard JH; Menda Y; Zamba KD; Madsen M; O'Dorisio MS; O'Dorisio T; Bushnell D
Cancer Biother Radiopharm; 2021 Oct; 36(8):632-641. PubMed ID: 34252288
[No Abstract] [Full Text] [Related]
28. [
Wang P; Li T; Liu Z; Jin M; Su Y; Zhang J; Jing H; Zhuang H; Li F
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3097-3106. PubMed ID: 37160439
[TBL] [Abstract][Full Text] [Related]
29. Myocardial adrenergic innervation in patients with vasovagal syncope measured with 123I-MIBG uptake.
Lorincz I; Garai I; Varga E; Barta K; Simkó J; Szabó Z; Galuska L; Varga J
Nucl Med Commun; 2009 Feb; 30(2):134-9. PubMed ID: 19194211
[TBL] [Abstract][Full Text] [Related]
30. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats.
Kiyono Y; Iida Y; Kawashima H; Ogawa M; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):999-1005. PubMed ID: 12173012
[TBL] [Abstract][Full Text] [Related]
31. On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.
Odagiri H; Baba T; Nishio Y; Iizuka O; Matsuda M; Inoue K; Kikuchi A; Hasegawa T; Aoki M; Takeda A; Taki Y; Mori E
PLoS One; 2016; 11(4):e0152746. PubMed ID: 27055151
[TBL] [Abstract][Full Text] [Related]
32. Clinical Significance of Quantitative 123I-MIBG SPECT/CT Analysis of Pheochromocytoma and Paraganglioma.
Nakamoto R; Nakamoto Y; Ishimori T; Togashi K
Clin Nucl Med; 2016 Nov; 41(11):e465-e472. PubMed ID: 27607159
[TBL] [Abstract][Full Text] [Related]
33. Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct.
Fagret D; Wolf JE; Comet M
Eur J Nucl Med; 1989; 15(9):624-8. PubMed ID: 2574671
[TBL] [Abstract][Full Text] [Related]
34. Relative uptake, metabolism, and beta-receptor binding of (1R,2S)-4-(18)F-fluorometaraminol and (123)I-MIBG in normotensive and spontaneously hypertensive rats.
Pissarek M; Ermert J; Oesterreich G; Bier D; Coenen HH
J Nucl Med; 2002 Mar; 43(3):366-73. PubMed ID: 11884497
[TBL] [Abstract][Full Text] [Related]
35. Iodine-123-metaiodobenzylguanidine SPECT of regional cardiac adrenergic denervation in Brugada syndrome.
Agostini D; Scanu P; Loiselet P; Babatasi G; Darlas Y; Grollier G; Potier JC; Bouvard G
J Nucl Med; 1998 Jul; 39(7):1129-32. PubMed ID: 9669381
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats.
Samnick S; Scheuer C; Münks S; El-Gibaly AM; Menger MD; Kirsch CM
Nucl Med Biol; 2004 May; 31(4):511-22. PubMed ID: 15093822
[TBL] [Abstract][Full Text] [Related]
37. [Characteristics of regional sympathetic dysfunction in acutely ischemic myocardium assessed by 123I-metaiodobenzylguanidine imaging: impairment of myocardial norepinephrine uptake or retention].
Ishida Y; Maeno M; Hirose Y; Takahashi N; Katabuchi T; Oka H; Hayashida K; Takamiya M; Nonogi H; Miyatake K
Kaku Igaku; 1995 Jul; 32(7):631-42. PubMed ID: 7674574
[TBL] [Abstract][Full Text] [Related]
38. Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT.
Nielsen JT; Nielsen BV; Rehling M
Clin Nucl Med; 1996 Sep; 21(9):695-9. PubMed ID: 8879869
[TBL] [Abstract][Full Text] [Related]
39. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
